Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children

NMR in Biomedicine

Volumn 18, Issue 4, 2005, Pages 213-225

  Subramanian, Arunachalam ^a   Gupta, Abhishek ^b   Saxena, Swapnil ^b   Gupta, Ashish ^c   Kumar, Raj ^c   Nigam, Anjali ^d   Kumar, Rashmi ^d   Mandal, Sudhir K ^a   Roy, Raja ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

^c SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^d KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

1H NMR; Cerebrospinal fluid; Differential diagnosis; Discriminant function analysis; Expert system; Meningitis; Metabolite quantification; Multivariate analysis

Indexed keywords

BACTERIA; COMPUTER SOFTWARE; DATABASE SYSTEMS; DIAGNOSIS; METABOLITES; NUCLEAR MAGNETIC RESONANCE; PROTONS;

FLUID METABOLITES; LACTATE; PREDICATORS;

DISEASES;

3 HYDROXYBUTYRIC ACID; ACETIC ACID; ACETOACETIC ACID; ACETONE; ALANINE; CITRIC ACID; CREATINE; CREATININE; CYCLOPROPANE; GLUTAMINE; LACTIC ACID; PYRUVIC ACID; UREA;

ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUBERCULOUS MENINGITIS; VALIDATION PROCESS; VIRUS MENINGITIS;

ALGORITHMS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENINGITIS; MULTIVARIATE ANALYSIS; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFTWARE;

EID: 21644465664     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.944     Document Type: Article

References (67)

1. Avery ME, First LR. Meningitis. In Pediatric Medicine, 2nd edn, Avery ME, First LR (eds). William & Wilkins: Baltimore, MD, 1994; 1164-1169.
2. Singhi PD, Singhi SC. Central nervous system infections in children (bacterial, tubercular). Curr. Opin. Neurol. 1995; 8: 150-155.
3. Tunkel AR, Scheld WM. Acute bacterial meningitis. Lancet 1995; 346: 1675-1680.
4. Behrman RE. In Nelson Textbook of Pediatrics, 15th edn, Behrman RE, Kliegman R, Jenson HB (eds). Saunders: Philadelphia, PA, 1996; 707-716.
5. McCracken GH Jr. Rich nations, poor nations, and bacterial meningitis. Lancet 2002; 360: 183.
6. Sáez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet 2003; 361: 2139-2148.
7. Upadyaya GC, Tripathi BN, Shukla RK, Singh KH. Tuberculous meningitis in children: Clinico laboratory correlation of CSF findings for early diagnosis. Ind. Pediatr. 1984; 51: 633-636.
8. Walia R, Hoskyns W. Tuberculous meningitis in children: problem to be addressed effectively with thorough contact tracing. Eur. J. Pediatr. 2000; 159: 535-538.
9. Narain S, Singhal T, Kabra SK, Seth V. Tuberculosis in HIV infection - facets of an epidemiologically lined co-infection. Paediatr. Today 2000; 3: 144-149.
10. Maxson S, Jacobs RF. Viral meningitis: Tips to rapidly diagnose treatable causes. Postgrad. Med. 1993; 93: 153-156, 159-160, 163-166.
11. O'Meara M, Ouvrier R. Viral encephalitis in children. Curr. Opin. Pediatr. 1996; 8: 11-15.
12. Panagariya A, Jain RS, Gupta S, Garg A, Sureka RK, Mathur V. Herps simplex encephalitis in North West India. Neurol. India 2001; 49: 360-365.
13. Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet 2002; 359: 507-514.
14. Moosa AA, Quortum HA, Ibrahim MD. Rapid diagnosis of bacterial meningitis with reagent strips. Lancet 1995; 345: 1290-1291.
15. Jinkins JR. Computed tomography of intracranial tuberculosis. Neurocardiology 1991; 36: 126-135.
16. Pagliano P, Fusco U, Attanasio V, Conte M, Maturo N, Prejan A, Fescigno C, Faella FS. Tuberculous meningitis in childhood: review of cases observed in the years 1995-1999. Infez. Med. 2001; 9: 246-250.
17. Pui MH, Memon WA. Magnetic resonance imaging findings in tuberculous meningoencephalitis. Can. Assoc. Radiol. J. 2001; 52: 43-49.
18. Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA 1979; 241: 264-268.
19. Mandal BK, Evan DZK, Iranside AG, Pollan BR. Radioactive bromide partition test for differential diagnosis of TBM. Br. Med. J. 1972; 4: 413-415.
20. Wiggelinkhoizen J, Mann M. The radioactive bromide partition test in the diagnosis of tuberculous meningitis. J. Pediatr. 1980; 97: 843-847.
21. Sharma B, Malik GK, Jain AK, Agarwal DK. Lactic dehydrogenase and its isoenzyme in TBM Indian. Pediatrics 1982; 79: 225-228.
22. Ribera E, Martinez-Vazquez JM, Segura RM, Pascual C. Activity of Adenosine deaminase in CSF for diagnosis and follow-up of TBM. J. Infect. Dis. 1987; 7: 603-607.
23. Pole SL, Khare PM, Kelkar SS. CSF IgG, A and M in pyogenic and tubercular meningitis. Ind. J. Pathol. Microbiol. 1983; 26: 193-199.
24. Pfyffer GE. Nucleic acid amplification for Mycobacterial diagnosis. J. Infect. 1999; 39: 21-26.
25. Thwaites GE, Chau TTH, Stepniewsak K, Phu NH, Choung LV, Sinh DX, White NJ, Parry CM, Farrar JJ. Diagnosis of Adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002; 360: 1287-1292.
26. Berkley JA, Mwangi I, Ngetsa CJ, Mwarumba S, Lowe BS, Marsh K, Newton CRJC. Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lancet 2001; 357: 1753-1757.
27. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173.
28. Petroff OAC, Yu RK, Ogino T. High-resolution proton magnetic resonance analysis of human cerebrospinal fluid. J. Neurochem. 1986; 47: 1270-1276.
29. Nicholson JK, Wilson ID. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog. NMR Spectrosc. 1989; 21: 449-501.
30. 12 deficient patient. NMR Biomed. 1991; 4: 192-200.
31. 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. J. Pharm. Biomed. Anal. 1993; 11: 651-664.
32. Ghauri FY, Nicholson JK, Sweatman BC, Wood J, Beddell CR, Lindon JC, Cairns NJ. NMR spectroscopy of human post mortem cerebrospinal fluid: Distinction of Alzheimer's disease from control using pattern recognition and statistics. NMR Biomed. 1993; 6: 163-167.
33. Hiraoka A, Miura I, Hattori M, Tominaga I, Kushida K, Maeda M. Proton magnetic resonance spectroscopy of cerebrospinal fluid as an aid in neurological diagnosis. Biol. Pharm. Bull. 1994; 17: 1-4.
34. Simone IL, Federico F, Trojano M, Tortorella C, Liguori M, Giannini P, Picciola E, Natile G, Livrea P. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques. J. Neurol. Sci. 1996; 144: 182-190.
35. Maillet S, Vion-Dury J, Confort-Gouny S, Nicoli F, Lutz NW, Viout P, Cozzone PJ. Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. Brain Res. Protocols 1998; 3: 123-134.
36. 1H NMR spectra of cerebrospinal fluid (CSF). FEBS Lett. 1998; 425: 345-351.
37. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13: 129-153.
38. 1H NMR studies of cerebrospinal fluid: endogenous ethanol in patients with cervical myelopathy. Clin. Chim. Acta 2001; 312: 25-30.
39. Henry CM. New 'ome' in town. Chem. Eng. News 2002; 80: 66-70.
40. 1H NMR spectroscopy of amniotic fluids from spina bifida fetuses and controls. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004; 112: 16-23.
41. Griffin JL. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr. Opin. Chem. Biol. 2003; 7: 648-654.
42. 1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease. J. Neurol. Sci. 2003; 212: 21-30.
43. Boss EA, Moolenaar SH, Massuger LF, Boonstra H, Engelke UF, de Jong JG, Wevers RA. High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid. NMR Biomed. 2000; 13: 297-305.
44. 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin. Chem. 1999; 45: 539-548.
45. Lisboa PJ, Kirby SP, Vellido A, Lee YY, El-Deredy W. Assessment of statistical and neural networks methods in NMR spectral classification and metabolite selection. NMR Biomed. 1998; 11: 225-234.
46. deCertaines JD. High resolution nuclear magnetic resonance spectroscopy in clinical biology: application in oncology. Anticancer Res. 1996; 16: 1325-1331.
47. Vion-Dury J, Nicoli F, Torri G, Torri J, Kriat M, Sciaky M, Davin A, Viout P, Confort-Gouny S, Cozzone PJ. High resolution NMR spectroscopy of physiological fluids: from metabolism to physiology. Biochimie 1992; 74: 801-807.
48. Bell JD, Brown JC, Sadler PJ. NMR studies of body fluids. NMR Biomed. 1989; 2: 246-256.
49. Bock JL. Nuclear magnetic resonance in the clinical laboratory. Am. J. Clin. Pathol. 1989; 91: S19-S26.
50. Learmonth MP, Euerby MR, Jacobs DE, Gibbons WA. Metabolite mapping of Toxocara canis using one- and two-dimensional proton magnetic resonance spectroscopy. Mol. Biochem. Parasitol. 1987; 25: 293-298.
51. Gilroy FV, Edwards MR, Norton RS, O'Sullivan WJ. Metabolic studies of the protozoan parasite, Crithidia luciliae, using proton nuclear magnetic resonance spectroscopy. Mol. Biochem. Parasitol. 1988; 31: 107-116.
52. Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed. 1997; 10: 2-12.
53. Moolenaar SH, Engelke UF, Wevers RA. Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann. Clin. Biochem. 2003; 40: 16-24.
54. Garg M, Chawla S, Prasad KN, Roy R, Sikora SS, Kumar R, Husain M, Khetrapal CL, Gupta RK. Differentiation of hydatid cyst from cysticercus cyst by proton MR spectroscopy. NMR Biomed. 2002; 15: 320-326.
55. Armitage P, Berry G. In Statistical Methods in Medical Research, 2nd edn, Armitage P, Berry G (eds). Blackwell & Scientific: Oxford, 1990; 472.
56. Fisher RA, Yates F. In Statistical Tables for Biological, Agricultural and Medical Research, 5th edn, Fisher RA, Yates F (eds). Oliver and Boyd: London, 1957; 126-131.
57. Potts BCM, Deese AJ, Stevens GJ, Reily MD, Robertson DG, Theiss J. NMR of biofluids and pattern recognition: assessing the impact of NMR parameters on the principal component analysis of urine from rat and mouse. J. Pharm. Biomed. Anal. 2001; 26: 463-476.
58. Fishman RA. In Cerebrospinal Fluid in Diseases of the Nervous System, Fishman RA (ed.). Saunders: Philadelphia, PA, 1980.
59. Gupta RK, Roy R, Dev R, Husain M, Poptani H, Pandey R, Kishore J, Bhaduri AP. Finger printing of Mycobacterium tuberculosis in patients with intracranial tuberculomas by using in vivo, ex vivo and in vitro magnetic resonance spectroscopy. Magn. Reson. Med. 1996; 36: 829-833.
60. Michal G. Biochemical pathways. In An Atlas of Biochemistry and Molecular Biology, Michal G (ed.). Wiley: New York, 1998.
61. Niroli F, Vion-Dury J, Maloteaux JM, Delwaide C, Confort-Gouny S, Sciaky M, Cozzone PJ. CSF and serum metabolic profile of patients with Huntington's chorea: a study by high resolution proton NMR spectroscopy and HPLC. Neurosci. Lett. 1993; 154: 47-51.
62. Heiblim DI, Evans HE, Glass L, Agbayani MM. Amino acid concentrations in cerebrospinal fluid. Arch. Neurol. 1978; 35: 765-768.
63. McGale EHF, Pye IF, Stonier C, Hutchison EC, Aber GM. Studies of the inter-relationship between cerebrospinal fluid and plasma amino acids in normal individuals. J. Neurochem. 1977; 29: 291-297.
64. Tucci S, Pinto C, Goyo J, Rada P, Hernandez L. Measurement of glutamine and glutamate by capillary electrophoresis and laser induced fluorescence detection in cerebrospinal fluid of meningitis sick children. Clin. Biochem. 1998; 31: 143-150.
65. Spranger M, Schwab S, Krempien S, Winterholler M, Steiner T, Hacke W. Excess glutamate levels in the cerebrospinal fluid predict clinical outcome of bacterial meningitis. Arch. Neurol. 1996; 53: 992-996.
66. Seiler N. Ammonia and Alzheimer's disease. Neurochem. Int. 2002; 41: 189-207.
67. Suarez I, Bodega G, Fernandez B. Glutamine synthetase in brain: effect of ammonia. Neurochem. Int. 2002; 41: 123-142.